Skip to content
HealthTech Series A Founded 2021

Ozette

Developer of computational drug discovery platform

📍 Seattle, United States · Life Sciences Tech

Funding snapshot

Last roundSeries A
Amount$26M
Date28 July 2022

About

Developer of computational drug discovery platform. It offers an AI-based single-cell immune monitoring platform for biomarker endpoints, comprehensive discovery, and annotation of cellular phenotypes. It enhances drug discovery for oncology, autoimmunity, and infectious diseases.

Latest news

No articles yet.

Raising like Ozette?

Analyze your pitch deck before your next raise.

Analyze My Deck →